JP2025507822A - 組換えヌクレアーゼならびにその組成物および使用方法 - Google Patents

組換えヌクレアーゼならびにその組成物および使用方法 Download PDF

Info

Publication number
JP2025507822A
JP2025507822A JP2024551902A JP2024551902A JP2025507822A JP 2025507822 A JP2025507822 A JP 2025507822A JP 2024551902 A JP2024551902 A JP 2024551902A JP 2024551902 A JP2024551902 A JP 2024551902A JP 2025507822 A JP2025507822 A JP 2025507822A
Authority
JP
Japan
Prior art keywords
amino acid
less
acid residues
sequence
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024551902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507822A5 (cg-RX-API-DMAC10.html
Inventor
ヤン,シャオ
エス. チ,レイ
キュティラス,ヴィンセント
アルバレス,ガブリエラ
ツェアウ,タビサ
オー. ハート,ダニエル
Original Assignee
エピクリスパー バイオテクノロジーズ, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エピクリスパー バイオテクノロジーズ, インコーポレイテッド filed Critical エピクリスパー バイオテクノロジーズ, インコーポレイテッド
Publication of JP2025507822A publication Critical patent/JP2025507822A/ja
Publication of JP2025507822A5 publication Critical patent/JP2025507822A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222—Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226—Class 2 CAS enzyme complex, e.g. single CAS protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024551902A 2022-03-01 2023-03-01 組換えヌクレアーゼならびにその組成物および使用方法 Pending JP2025507822A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263315159P 2022-03-01 2022-03-01
US63/315,159 2022-03-01
US202263380178P 2022-10-19 2022-10-19
US63/380,178 2022-10-19
US202263385171P 2022-11-28 2022-11-28
US63/385,171 2022-11-28
PCT/US2023/063446 WO2023168242A1 (en) 2022-03-01 2023-03-01 Engineered nucleases, compositions, and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025507822A true JP2025507822A (ja) 2025-03-21
JP2025507822A5 JP2025507822A5 (cg-RX-API-DMAC10.html) 2026-02-27

Family

ID=87884328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024551902A Pending JP2025507822A (ja) 2022-03-01 2023-03-01 組換えヌクレアーゼならびにその組成物および使用方法

Country Status (8)

Country Link
US (2) US12054756B2 (cg-RX-API-DMAC10.html)
EP (1) EP4486882A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025507822A (cg-RX-API-DMAC10.html)
KR (1) KR20240152394A (cg-RX-API-DMAC10.html)
CN (1) CN119137268B (cg-RX-API-DMAC10.html)
AU (1) AU2023229364A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253017A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023168242A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230076820A (ko) 2020-09-01 2023-05-31 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
WO2025231397A1 (en) * 2024-05-03 2025-11-06 Tenaya Therapeutics, Inc. Modified hek cell lines for improved aav production
CN118315068B (zh) * 2024-05-15 2025-08-08 西湖实验室(生命科学和生物医学浙江省实验室) 基于蛋白标志物预测卵巢癌患者化疗敏感性的装置、蛋白标志物分类器的构建方法和应用
WO2025264819A1 (en) * 2024-06-18 2025-12-26 Nchroma Bio, Inc. Compositions and methods for epigenetic regulation of znf410 expression

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
WO2015089473A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
AU2016279062A1 (en) 2015-06-18 2019-03-28 Omar O. Abudayyeh Novel CRISPR enzymes and systems
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US11352647B2 (en) 2016-08-17 2022-06-07 The Broad Institute, Inc. Crispr enzymes and systems
CN117487776A (zh) * 2017-11-01 2024-02-02 加利福尼亚大学董事会 Casz组合物和使用方法
WO2019089808A1 (en) * 2017-11-01 2019-05-09 The Regents Of The University Of California Class 2 crispr/cas compositions and methods of use
US11667917B2 (en) 2017-11-21 2023-06-06 Genkore Co. Ltd. Composition for genome editing using CRISPR/CPF1 system and use thereof
EP3875469A4 (en) 2018-10-29 2022-08-17 China Agricultural University NOVEL CRISPR/CAS12F ENZYME AND SYSTEM
US12258594B2 (en) 2018-12-05 2025-03-25 The Broad Institute, Inc. Cas proteins with reduced immunogenicity and methods of screening thereof
CN113166744B (zh) 2018-12-14 2025-02-07 先锋国际良种公司 用于基因组编辑的新颖crispr-cas系统
EP4219700A1 (en) * 2019-03-07 2023-08-02 The Regents of the University of California Crispr-cas effector polypeptides and methods of use thereof
WO2020223634A1 (en) 2019-05-01 2020-11-05 Mammoth Biosciences, Inc. Programmable nucleases and methods of use
EP3772329A1 (fr) * 2019-08-08 2021-02-10 PKvitality Systeme de surveillance corporelle comprenant une microaiguille
IL292571A (en) * 2019-10-28 2022-06-01 Targetgene Biotechnologies Ltd Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation
CN114846146B (zh) 2019-10-29 2024-04-12 基恩科雷有限责任公司 用于增加CRISPR/Cas12f1系统的效率的工程化引导RNA及其用途
KR20230076820A (ko) 2020-09-01 2023-05-31 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
CN116568803A (zh) 2020-10-08 2023-08-08 基恩科雷有限责任公司 用于增加CRISPR/Cas12f1系统的效率的包含富含U的尾部的经工程化的引导RNA及其用途
JP2023544817A (ja) 2020-10-08 2023-10-25 ゲンコレ インコーポレイテッド CRISPR/Cas12f1システム効率化のためのエンジニアリングされたガイドRNAおよびその用途
WO2022075816A1 (ko) 2020-10-08 2022-04-14 주식회사 진코어 Crispr/cas12f1(cas14a1) 시스템 효율화를 위한 엔지니어링 된 가이드 rna 및 이의 용도
EP4267252A4 (en) 2020-12-23 2025-07-23 Mammoth Biosciences Inc COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES TO INDUCE CELL DEATH
US20240060088A1 (en) 2021-01-05 2024-02-22 Horizon Discovery Limited Guide RNA Designs and Complexes for Type V Cas Systems
JP2024523394A (ja) 2021-06-17 2024-06-28 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 異常な遺伝子発現を調節するためのシステムおよび方法
KR20230007218A (ko) * 2021-07-05 2023-01-12 주식회사 진코어 초소형 염기교정 시스템 및 이의 용도
JP2024526895A (ja) 2021-07-20 2024-07-19 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 標的遺伝子を調節するための系および方法
AU2022318664A1 (en) 2021-07-30 2024-02-29 Tune Therapeutics, Inc. Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
WO2023172995A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Systems and methods for genetic modulation to treat ocular diseases
WO2023173120A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Systems and methods for genetic modulation to treat ocular diseases
EP4490294A4 (en) 2022-03-11 2026-03-18 Epicrispr Biotechnologies Inc GENETIC MODULATION SYSTEMS AND METHODS FOR TREATING LIVER DISEASE
WO2023173110A1 (en) 2022-03-11 2023-09-14 Epicrispr Biotechnologies, Inc. Compositions, systems, and methods for treating familial hypercholesterolemia by targeting pcsk9
JP2025510781A (ja) 2022-03-24 2025-04-15 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換え遺伝子エフェクターならびにその組成物および使用方法

Also Published As

Publication number Publication date
KR20240152394A (ko) 2024-10-21
CN119137268A (zh) 2024-12-13
US20250011742A1 (en) 2025-01-09
CN119137268B (zh) 2026-07-17
US20240035009A1 (en) 2024-02-01
EP4486882A4 (en) 2025-09-17
AU2023229364A1 (en) 2024-09-19
US12054756B2 (en) 2024-08-06
EP4486882A1 (en) 2025-01-08
CA3253017A1 (en) 2023-09-07
WO2023168242A1 (en) 2023-09-07

Similar Documents

Publication Publication Date Title
US20220025369A1 (en) Rna encoding a therapeutic protein
JP7794719B2 (ja) 細胞の品質管理方法及び細胞を製造する方法
US20240165239A1 (en) Covalent Binding Compounds for the Treatment of Disease
US20230193205A1 (en) Gene modified fibroblasts for therapeutic applications
US20220401460A1 (en) Modulating resistance to bcl-2 inhibitors
US10793914B2 (en) Cancer-related biological materials in microvesicles
CN110499364A (zh) 一种用于检测扩展型遗传病全外显子的探针组及其试剂盒和应用
AU2022312308B2 (en) Method for managing quality of specific cells, and method for manufacturing specific cells
CN117730164A (zh) 细胞的品质管理方法及制造细胞的方法
US12160984B2 (en) Radio wave absorber
US12054756B2 (en) Engineered nucleases, compositions, and methods of use thereof
US20250388634A1 (en) Engineered gene effectors, compositions, and methods of use thereof
CN117677707A (zh) 特定细胞的品质管理方法及制造特定细胞的方法
US20250305061A1 (en) Methods and systems for inferring gene expression using cell-free dna fragments
WO2026062505A1 (en) Methods and systems for detecting an organ or a tissue impacted by a cancer or a disease, disorder or condition
US20260085300A1 (en) Systems and compositions for fusion polypeptides and methods of use thereof
US20220326216A1 (en) T cell gene expression analysis for use in t cell therapies
CN121532411A (zh) 用于调控靶基因的系统和方法
Schwarzer et al. Supplementary Data from Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1 [Dataset]
HK40109321A (en) Method for managing quality of specific cells, and method for manufacturing specific cells
HK40109609A (en) Cell quality management method and cell production method

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240919

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20250205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260218